Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug development academia

The comprehensive profile of drug substances and pharmaceutical excipients as to their physical and analytical characteristics continues to be an essential feature of drug development. The compilation and publication of comprehensive summaries of physical and chemical data, analytical methods, routes of compound preparation, degradation pathways, uses and applications, etc., is a vital function to both academia and industry. It goes without saying that workers in the field require access to current state-of-the-art data, and the Analytical Profiles series has always provided information of the highest quality. For this reason, profiles of older compounds are updated whenever a sufficient body of new information becomes available. [Pg.532]

In this book the current state of affairs with regard to the medicinal chemistry and pharmacology of the H3 receptor and the several ligands available are presented by a number of experts in the field. The book presents an extended review of what has happened since the first H3 paper appeared. We hope that this work will lead to an increase of the interest, of both academia and industry, for the H3 receptor, especially as a target for drug development. [Pg.303]

For several years, the widespread application of PK/PD concepts in all phases of drug development has repeatedly been promoted by industry, academia, and regulatory authorities [11-16]. Rigorous implementation of PK/PD concepts in drug product development provides a rationale, scientifically based framework for efficient decision-making regarding the selection of potential drag candidates, for... [Pg.8]

One of CDER s primary goals is to work collaboratively and cooperatively with industry, academia, and others to improve the drug development and review process. It also strives to provide consumers and health care providers with drug information that is vital to improving the public health. The topics listed below provide an overview of the various means of communicating with CDER. [Pg.399]

Drug Development Science Obstacles and Opportunities for Collaboration Among Academia, Industry and Government. Association of American Medical Colleges, EDA Department of Health Human Services, Rockville, MD, 2005. https //services. aamc. org/. [Pg.924]


See other pages where Drug development academia is mentioned: [Pg.516]    [Pg.294]    [Pg.276]    [Pg.184]    [Pg.222]    [Pg.345]    [Pg.503]    [Pg.616]    [Pg.105]    [Pg.281]    [Pg.110]    [Pg.96]    [Pg.3]    [Pg.467]    [Pg.11]    [Pg.412]    [Pg.195]    [Pg.271]    [Pg.567]    [Pg.479]    [Pg.183]    [Pg.82]    [Pg.147]    [Pg.245]    [Pg.33]    [Pg.459]    [Pg.523]    [Pg.285]    [Pg.9]    [Pg.203]    [Pg.257]    [Pg.2]    [Pg.190]    [Pg.1221]    [Pg.439]    [Pg.361]    [Pg.24]    [Pg.169]    [Pg.51]    [Pg.55]    [Pg.68]    [Pg.113]    [Pg.9]   
See also in sourсe #XX -- [ Pg.107 ]




SEARCH



Academia

© 2024 chempedia.info